Jasper Therapeutics, Inc. (NASDAQ:JSPR – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are covering the company, MarketBeat Ratings reports. Nine analysts have rated the stock with a buy rating. The average twelve-month target price among analysts that have issued ratings on the stock in the last year […]

Related Keywords

Monaco , Canada , , Jasper Therapeutics Inc , Royal Bank , Fernwood Investment Management , Opaleye Management Inc , Nasdaq , Jasper Therapeutics , Get Free Report , Marketbeat Ratings , Investment Management , Asset Management , Get Free , Jasper Therapeutics Daily ,